BioSpace News Archive

U.S. Department of Defense Awards Grant to SiteOne Therapeutics, Supporting Research and Development of Selective Small Molecule NaV1.7 Inhibitors as Acute and Chronic Pain Therapeutics

“There is a critical need for non-opioid therapeutics that treat acute and chronic pain effectively, allowing for less reliance on opioids, and reducing the side effects and addiction potential associated with them.”

November 7, 2017

·

3 min read

Drug Development

Janssen’s New Phase II Data Show Treatment With TREMFYA (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year

According to findings presented at the 2017 ACR/ARHP Annual Meeting, more than 70 percent of patients receiving TREMFYA 100 mg subcutaneous injections achieved at least a 20 percent improvement in signs and symptoms of disease using observed data at week 56.

November 7, 2017

·

11 min read

FDA

Aytu BioScience Receives Market Approval From the Australian Therapeutic Goods Administration for the MiOXSYS System for Male Infertility

MiOXSYS has been approved by the TGA as an aid in the diagnostic assessment of semen quality for patients undergoing male infertility evaluation.

November 7, 2017

·

4 min read

Drug Development

Results From Alligator Bioscience’s Clinical Phase I Study Support Further Clinical Development of ADC-1013

The study results show that ADC-1013 is generally well tolerated and support further clinical development of ADC-1013 as a mono- or combination therapy.

November 7, 2017

·

5 min read

Biotech Beach

Tear Film Innovations Completes $9 Million Series A Funding

Tear Film Innovations, Inc. (TFI) announced today it has completed a $9 million Series A Preferred Stock funding round led by Visionary Ventures Fund, L.P. and Tigris Ventures, LLC.

November 7, 2017

·

3 min read

Business

Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer

Dr. McNiece has spent 30 years in both academic and commercial settings working in the areas of stem cell biology and clinical manufacturing for bone marrow transplantation and cellular therapy clinical applications.

November 7, 2017

·

4 min read

CRH Medical Receives TSX Approval for Normal Course Issuer Bid

CRH Medical announces that it has received approval from the TSX of its Notice of Intention to Make a Normal Course Issuer Bid (the “Bid”).

November 7, 2017

·

11 min read

Baxter Presents Data on the Role of SHARESOURCE Telehealth Platform in Helping the Clinical Management of Peritoneal Dialysis Patients

Presented at the American Society of Nephrology’s annual Kidney Week Congress, Oct. 31- Nov. 5, the exploratory studies show how SHARESOURCE data may provide an early indicator of impending peritonitis, or evidence of PD catheter dysfunction.

November 7, 2017

·

6 min read

Business

Zynex Schedules 2017 Third Quarter Earnings Release and Webcast

The Company expects to file its 2017 third quarter financial results on Monday, November 13, 2017.

November 7, 2017

·

2 min read

Policy

Novoclem Therapeutics Receives QIDP Status for its Lead Inhaled Antimicrobial Drug Candidate

The QIDP designation, granted for treatment of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis, will make BIOC51 eligible to benefit from certain incentives for the development of new antibiotics provided under the Generating Antibiotic Incentives Now Act.

November 7, 2017

·

3 min read